About
Manaolana Oncology is a biotechnology company developing novel antibody-based oncology therapeutics, including antibody-drug conjugates, through a joint venture with The University of Texas MD Anderson Cancer Center using large cancer patient datasets and tissue repositories to identify new cancer targets.
Explore Manaolana Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.